Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WGS vs NEO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NEO Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
NEO Overall Winner
6-Pillar Tally: WGS 2 – 4 NEO
Matrix Metrics: WGS 3 – 7 NEO
As of Nov 16, 2026, NeoGenomics, Inc. (NEO) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin).
- Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEO 35.0/100 SELL), NEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-5.5% vs. -13.7% operating margin) and revenue trajectory (+11.4% vs. +5.4% YoY).
- Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About WGS vs NEO
WGS
GeneDx Holdings Corp. Class A Common Stock
$51.02
-2.58% 1D
Market Cap
$1.6B
TTM Revenue
$461M
Forward P/E
40.6x
Beta / 30D Vol
1.74β · 111% Vol
Unified Composite Score
49.5
HOLD
Tech 33.0
Fund 53.0
Flow 70.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
NEO
Head-to-Head Winner
NeoGenomics, Inc.
$15.41
-3.81% 1D
Market Cap
$2.1B
TTM Revenue
$788M
Forward P/E
N/M
Beta / 30D Vol
1.22β · 47% Vol
Unified Composite Score
35.0
SELL
Tech 21.0
Fund 44.0
Flow 58.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (WGS 2 – 4 NEO)
1. Valuation Multiples
WGS
Forward P/E
40.6x
N/M
Trailing P/E
38.8x
N/M
PEG Ratio
N/M
2.09x
EV / Revenue
3.7x
3.0x
2. Growth & Scale
NEO
Revenue Growth (YoY)
+5.4%
+11.4%
Earnings Growth (YoY)
+0.0%
+130.6%
TTM Revenue (USD)
$461M
$788M
Market Cap
$1.6B
$2.1B
3. Profitability & Quality
NEO
Gross Margin
68.8%
44.8%
Operating Margin
-13.7%
-5.5%
Net Profit Margin
-24.1%
-4.1%
Return on Equity (ROE)
-41.4%
-3.9%
4. Balance Sheet & Cash Flow
NEO
Cash Generation (TTM)
-$101M
-$29M
Cash Flow Margin
-22.0%
-3.6%
Net Cash / Leverage
$119M Net Debt (0.88x D/E)
$310M Net Debt (0.56x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
NEO
Options Structure Phase
BREAKDOWN
CONSOLIDATION
Current IV / %ile
102.3% (21st %ile)
100.0% (14th %ile)
Put/Call OI Skew
7.82x (Put-Skewed)
0.12x (Call-Skewed)
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
WGS
OpEx & R&D Intensity
82.5% of Rev ($380M)
50.3% of Rev ($396M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Diagnostics & Research Operator
Diagnostics & Research Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: WGS (3) vs NEO (7)| Institutional Metric | WGS | NEO | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $1.6B | $2.1B | NEO | |
| Trailing P/E Ratio | 38.8x | N/M | WGS | |
| Forward P/E Ratio | 40.6x | N/M | WGS | |
| Revenue Growth (YoY) | +5.4% | +11.4% | NEO | |
| Operating Margin (TTM) | -13.7% | -5.5% | NEO | |
| Net Profit Margin | -24.1% | -4.1% | NEO | |
| Return on Equity (ROE) | -41.4% | -3.9% | NEO | |
| 52-Week Range Position | 14% ($32–$171) | 64% ($7–$20) | NEO | |
| Beta / 30D Volatility | 1.74β · 111% Vol | 1.22β · 47% Vol | NEO | |
| Unified Institutional Score | 49.5 / 100 (HOLD) | 35.0 / 100 (SELL) | WGS | |
| Trailing 12M Revenue (USD) | $461M | $788M | Scale | |
| Gross Profit Margin (TTM) | 68.8% | 44.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 3.7x EV/Rev | 2.09x PEG · 3.0x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$101M ($119M Net Debt (0.88x D/E)) | -$29M ($310M Net Debt (0.56x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
NEO +12.34 pp
3M Horizon
NEO +30.09 pp
6M Horizon
NEO +64.6 pp
1Y Horizon
NEO +114.81 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | WGS Revenue | NEO Revenue | WGS Op. Margin | NEO Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | N/A | $280M | N/A | 3.6% | NEO |
| FY2019 | $200M | $410M | -15.5% | 3.2% | NEO |
| FY2020 | $180M | $440M | -134.9% | -3.1% | NEO |
| FY2021 | $210M | $480M | -210.3% | -24.5% | NEO |
| FY2022 | $230M | $510M | -284.5% | -30.9% | NEO |
| FY2023 | $200M | $590M | -89.2% | -18.2% | NEO |
| FY2024 | $310M | $660M | -7.6% | -13.9% | WGS |
| FY2025 | $430M | $730M | -3.1% | -15.9% | WGS |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
WGS
BREAKDOWN
Current IV
102.3%
IV Percentile
21st %ile
Put/Call OI Skew
7.82x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact WGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
NEO
CONSOLIDATION
Current IV
100.0%
IV Percentile
14th %ile
Put/Call OI Skew
0.12x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact NEO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
WGS Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
82.5% of Rev ($380M)
90D Engineering Disclosures
0 Published
NEO Moat Profile
Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
OpEx & R&D Reinvestment
50.3% of Rev ($396M)
90D Engineering Disclosures
0 Published
Investor FAQ WGS vs NEO Key Questions & Quantitative Answers
As of Nov 16, 2026, NeoGenomics, Inc. (NEO) is the stronger overall head-to-head candidate over GeneDx Holdings Corp. (WGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WGS carries a Unified Composite Score of 49.5/100 (HOLD) at $51.02 (40.6x Forward P/E, -13.7% operating margin), whereas NEO carries 35.0/100 (SELL) at $15.41 (N/M Forward P/E, -5.5% operating margin). Composite vs. Pillar Nuance: While WGS currently prints a higher short-term Unified Composite Score (49.5/100 HOLD vs. NEO 35.0/100 SELL), NEO captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-5.5% vs. -13.7% operating margin) and revenue trajectory (+11.4% vs. +5.4% YoY). Technical & Structure Timing Caution: WGS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8); meanwhile NEO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NEO leads the Growth & Scale pillar: WGS posts +5.4% YoY revenue growth and +0.0% YoY earnings growth on $461M TTM revenue (68.8% gross margin, -13.7% operating margin), compared with NEO at +11.4% YoY revenue growth and +130.6% YoY earnings growth on $788M TTM revenue (44.8% gross margin, -5.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), WGS cumulative revenue shifted +115.0% while NEO shifted +160.7%. In operating R&D and SG&A reinvestment, WGS deploys 82.5% of Rev ($380M) (0 90-day corporate R&D disclosures) versus 50.3% of Rev ($396M) (0 disclosures) for NEO.
WGS screens cheaper on headline valuation multiples. WGS trades at 40.6x Forward P/E, 38.8x Trailing P/E, N/M PEG, and 3.7x EV/Revenue (-22.0% FCF margin), whereas NEO trades at N/M Forward P/E, N/M Trailing P/E, 2.09x PEG, and 3.0x EV/Revenue (-3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WGS (-41.4% ROE) versus NEO (-3.9% ROE) capital efficiency.
In options market volatility and institutional positioning, WGS carries 102.3% implied volatility (21st %ile, Compressed (<25th %ile)), a 7.82x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.74β · 111% Vol realized risk). By comparison, NEO carries 100.0% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.12x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.22β · 47% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
NEO vs WGS · Reverse Pair
WGS vs SEZL
· Sector Peer
WGS vs GRAL
· Sector Peer
WGS vs NTRA
· Sector Peer
NEO vs VCYT
· Sector Peer
NEO vs NVCR
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem